ClosedResearch

Cancer Genomics Clinical Trials Fund: SCCT Program

Cancer Australia · Australia

The Cancer Genomics Clinical Trials Fund is a one-off grant opportunity under the Support for Cancer Clinical Trials program. It provides additional investment to Australia's multi-site collaborative cancer clinical trials groups to build capacity and accelerate the incorporation of genomics into cancer clinical trial design and protocols over three years.

Official Grant Page

Closed

7 Apr 2026

Duration

3 years

Location

Australia

Who Can Apply

Only administering bodies representing the 14 nationally recognised CTGs in the SCCT program may apply. Applicants must be one of the organisations listed in Section 4.1 of the Grant Opportunity Guidelines. Only listed organisations will be invited to apply. Joint consortia applications may be accepted under section 7.2 of the guidelines.
Applications can only be accepted from the Administering Bodies that represent the 14 nationally recognised Clinical Trials Groups participating in the Support for Cancer Clinical Trials program. To be eligible, applicants must be one of the organisations listed under Section 4.1 of the Grant Opportunity Guidelines, and only listed organisations will be invited to apply. Joint consortia applications may be accepted in accordance with section 7.2 of the Grant Opportunity Guidelines.

What's Funded

Activities that build capacity within nationally recognised cancer clinical trials groups and develop approaches and methods to incorporate genomics into the design of cancer clinical trial concepts and protocols.

Expected Outcomes

Improved capability of participating clinical trials groups, development of genomics-informed trial concepts and protocols, and faster incorporation of genomics into cancer clinical trials across the supported groups.

Key Information

Applicant Types

non_profituniversityother

Stage

established

Funding Purposes

researchinnovationcapacity_expenditureother

Keywords

cancergenomicsclinical trialshealth and medical researchCancer AustraliaSCCTcapacity buildingmedical research

Frequently Asked Questions

What is the Cancer Genomics Clinical Trials Fund: SCCT Program?

The Cancer Genomics Clinical Trials Fund: SCCT Program is a research grant offered by Cancer Australia in Australia. The Cancer Genomics Clinical Trials Fund is a one-off grant opportunity under the Support for Cancer Clinical Trials program. It provides additional investment to Australia's multi-site collaborative cancer clinical trials groups to build capacity and accelerate the incorporation of genomics into cancer clinical trial design and protocols over three years.

Who is eligible for the Cancer Genomics Clinical Trials Fund: SCCT Program?

Only administering bodies representing the 14 nationally recognised CTGs in the SCCT program may apply. Applicants must be one of the organisations listed in Section 4.1 of the Grant Opportunity Guidelines. Only listed organisations will be invited to apply. Joint consortia applications may be accepted under section 7.2 of the guidelines.

When does the Cancer Genomics Clinical Trials Fund: SCCT Program close?

Applications closed on 7 Apr 2026.

What activities are funded?

Activities that build capacity within nationally recognised cancer clinical trials groups and develop approaches and methods to incorporate genomics into the design of cancer clinical trial concepts and protocols.

How do I apply for the Cancer Genomics Clinical Trials Fund: SCCT Program?

Start by checking your eligibility using the free Beta Docs eligibility checker. If eligible, Beta Docs' AI-powered platform can help you draft, review, and refine your application to maximise your chances of success.

Need help applying?

Beta Docs has helped founders secure $160M+ in competitive grants. Our AI platform drafts compliance-perfect applications — and our expert reviewers make sure you stand out.

Start with Beta DocsBook a free consultation